National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci speaks during an April meeting between President Trump and Gov. John Bel Edwards, D-La. Fauci is one of the officials in a self-quarantine now.

National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci speaks during an April meeting between President Trump and Gov. John Bel Edwards, D-La. Fauci is one of the officials in a self-quarantine now. Evan Vucci / AP

Coronavirus Roundup: Top Federal Officials Self-Quarantine; Updates on SBA, HHS, EPA and Defense Inspector General Probes

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

President Trump tweeted on Monday morning, “Coronavirus numbers are looking MUCH better, going down almost everywhere. Big progress being made!” Meanwhile, various top federal officials (Centers for Disease Control and Prevention Director Robert Redfield; National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci; Food and Drug Administration Commissioner Dr. Stephen Hahn; Chief of the U.S. National Guard Gen. Joseph Lengyel and Chief of Naval Operations Adm. Michael Gilda) are self-quarantining due to possible coronavirus exposure. White House Economic Adviser Kevin Hassert said on CBS on Sunday that going to work in the West Wing is “a little bit risky...but you have to do it because you have to serve your country.” Here are some other recent headlines from over the weekend and today you might have missed. 

Sen. Chuck Schumer, D-N.Y., asked the Veterans Affairs Department to explain why it’s using the drug hydroxychloroquine on some veterans, which is not a proven coronavirus treatment yet. The administration’s push to use hydroxychloroquine was a central part of demoted vaccine official Dr. Rick Bright’s whistleblower complaint. “VA only permits use of the drug after ensuring veterans and caretakers are aware of potential risks associated with it, as we do with any other drug or treatment,” said VA Spokeswoman Christina Noel, the Associated Press reported on Sunday. 

Bright pushed back on the president’s claims he was a “disgruntled employee” in an interview CBS’ 60 minutes set to air on May 17. "I am frustrated at a lack of leadership," he said. "I am frustrated at a lack of urgency to get a head start on developing lifesaving tools for Americans. I'm frustrated at our inability to be heard as scientists. Those things frustrate me." 

Citing a statement from Bright’s attorneys, The New York Times reported on Friday the Office of Special Counsel found “reasonable grounds to believe” the Trump administration retaliated against Bright and said he should be reinstated for 45 days while an investigation takes place. OSC told Government Executive it could not “comment on or confirm the status of open investigations.”

The Government Accountability Project, a whistleblower advocacy group, published new guides for government employee and contractor whistleblowers. One of them is specifically about “speaking up for science.” 

Top House Democrats wrote to the Homeland Security and Transportation departments on Friday asking them to create an interagency working group to address air travel during the pandemic.  “Although passenger volume has dramatically decreased, frontline employees are still going to work and aircraft are still flying,” they wrote. “Frontline workers and airline passengers, subject to varying requirements, continue to comingle in public areas, secure areas, and finally on aircraft. Inconsistency creates uncertainty and limits the effectiveness of the actions taken.”

Similarly, another group of top House Democrats urged House leadership on Friday to establish an independent and bipartisan commission composed of outside experts in the next coronavirus relief package. The commission would “complement” Congress’ oversight efforts and mirror the 9/11 commission. “Currently at least four proposals [are] introduced in the House to establish bipartisan commissions. Collectively, they have been cosponsored by 54 Members of Congress, 40 Democrats and 14 Republicans,” they wrote. “While there are important differences in what has been proposed, there are far more commonalities.”

On Friday, the Indian Health Service announced five new projects to expand health care facilities for American Indian and Alaska Native people under its joint venture construction program with tribes nationwide. Read more here

Former Vice President Joe Biden, the presumptive Democratic nominee for president, published an article in The Washington Post on Monday criticizing the Trump administration’s handling of the coronavirus outbreak and arguing what should be done. “If we’re going to have thriving workplaces, restaurants, stores and parks, we need widespread testing,” he wrote. “Trump can’t seem to provide it — to say nothing of worker safety protocols, consistent health guidelines or clear federal leadership to coordinate a responsible reopening.” If elected, Biden could be in charge of overseeing subsequent waves of the coronavirus or recovery efforts from the current one. 

Capitol police officers are now required to wear masks when in close contact with others, Roll Call reported on Friday. This comes a month after the Centers for Disease Control and Prevention recommended individuals wear face coverings. 

House Majority Leader Steny Hoyer, D-Md., launched a new website to share information about congressional committees’ pandemic-related work. This includes hearings, reports, forums and other resources. 

The House Select Subcommittee on the Coronavirus Crisis announced its first official action on Friday. The panel, led by House Majority Whip James Clyburn, D-S.C., sent letters to five large, public corporations demanding they return the relief funds they received that were intended for small businesses. 

The Small Business Administration inspector general said in a "flash report" on Friday that the agency didn’t follow all congressional mandates in its distribution of relief loans under the Paycheck Protection Program. For example, “Because SBA did not provide guidance to lenders about prioritizing borrowers in underserved and rural markets, these borrowers, including rural, minority and women-owned businesses may not have received loans as intended,” said the report. 

The Defense Department IG said on Monday it will begin a review of the Navy’s policies, procedures and migration strategies in response to the coronavirus. Two ships suffered outbreaks, one of which led to much leadership turmoil. 

The Health and Human Services IG announced on Friday a report about the agency’s need to bolster security controls to prevent cyber attacks. “Due to the current public health emergency and increased cyber-activity, we are only posting the title of our cybersecurity audits,” said the office. This follows reports of an attempted cyber attack on HHS in March and the FBI warning of increased cyber threats during the pandemic, as NextGov reported. 

The Environmental Protection Agency IG will review how the pandemic impacted the EPA’s "programs and operations, regulatory and enforcement missions, and mandated activities,” according to a memo obtained by The Hill. The IG will also examine how the agency “conducted and is conducting its oversight and programmatic responsibilities to protect public health and the environment” during this time. 

The FDA announced on Saturday it issued its first emergency authorization for a coronavirus antigen test, which can be used for rapid detection of the virus. However, it noted, “negative results from an antigen test may need to be confirmed with a [polymerase chain reaction] test prior to making treatment decisions or to prevent the possible spread of the virus due to a false negative.”

The Health and Human Services Department plans to ship 14,400 vials of remdesivir, the only drug approved to treat coronavirus, to state health departments, which will decide which hospitals will get them. “Previously the administration had sent a total of 35,360 vials straight to a handpicked list of hospitals, via its contractor AmerisourceBergen,” Politico reported on Saturday.

Top National Institutes of Health experts said there needs to be a “harmonized and collaborative approach” to scale-up coronavirus vaccine testing and distribution. Read the full article published in Science Magazine on Monday. “The authors emphasize that developing COVID-19 vaccines will require unprecedented cooperation from governments, academic institutions, industry, and global philanthropic partners,” said the NIH.  The “public-private partnership spearheaded by NIH aims to facilitate such collaboration with discussions and collaborations on trial designs and data sharing.” 

DHS and the Justice Department said that starting on Sunday in-person document services for migrant protection protocol hearings will be suspended until June 8 and hearings are now postponed through June 19. “DHS and [the Executive Office for Immigration Review] are deeply committed to ensuring the health and safety of aliens, our frontline officers, immigration court professionals and our citizens,” they said.

Today’s GovExec Daily podcast episode digs into the testimony last week of Brian Miller, Trump's nominee to be Special Inspector General for Pandemic Recovery. Miller is currently special assistant and senior associate counsel in the Office of White House Counsel and a former IG for the General Services Administration. 

Upcoming: President Trump and administration officials will hold a briefing on coronavirus testing at 4 p.m. 

Fauci, Redfield, Hahn and Adm. Brett Giroir, HHS official overseeing testing efforts, will testify before a Senate committee Tuesday at 10 a.m. 

Help us understand the situation better. Are you a federal employee, contractor or military member with information, concerns, etc. about how your agency is handling the coronavirus? Email us at newstips@govexec.com.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.